Evidence map›Paper›PMID 35448169›Full record

ArticleCurrent oncology (Toronto, Ont.)2022

Operationalizing Leadership and Clinician Buy-In to Implement Evidence-Based Tobacco Treatment Programs in Routine Oncology Care: A Mixed-Method Study of the U.S. Cancer Center Cessation Initiative.

Sarah D Hohl, Jennifer E Bird, Claire V T Nguyen, Heather D'Angelo, Mara Minion, Danielle Pauk, Robert T Adsit, Michael Fiore, Margaret B Nolan, Betsy Rolland

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sarah D HohlCarbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.ORCID 0000-0002-4624-1868
Jennifer E BirdCarbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.ORCID 0000-0002-4597-0348
Claire V T NguyenCarbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.
Heather D'AngeloCarbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.
Mara MinionCarbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.ORCID 0000-0002-9759-302X
Danielle PaukCarbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.
Robert T AdsitCarbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.
Michael FioreCarbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.
Margaret B NolanCarbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.
Betsy RollandCarbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDelivering evidence-based tobacco dependence treatment in oncology settings improves smoking abstinence and cancer outcomes. Leadership engagement/buy-in is critical for implementation success, but few studies have defined buy-in or described how to secure buy-in for tobacco treatment programs (TTPs) in cancer care. This study examines buy-in during the establishment of tobacco treatment programs at National Cancer Institute (NCI)-designated cancer centers.

methodsWe utilized a sequential, explanatory mixed-methods approach to analyze quantitative data and qualitative interviews with program leads in the U.S.-based NCI Moonshot-supported Cancer Center Cessation Initiative (

resultsAt least 75% of participating centers secured health care system administrative, clinical, and IT leadership buy-in and support. Six themes emerged from interviews: engaging leadership, access to resources, leveraging federal funding support to build leadership interest, designating champions, identifying training needs, and ensuring staff roles and IT systems support workflows.

conclusionsBuy-in among staff and clinicians is defined by the belief that the TTP is necessary, valuable, and evidence based. Recognizing and securing these dimensions of buy-in can facilitate implementation success, leading to improved cancer outcomes.

Indexed as

NeoplasmsSmoking CessationHumansLeadershipMedical OncologyNational Cancer Institute (U.S.)NicotianaUnited Statescancer survivorshipcancer treatmentclinical championevidence-based tobacco dependence treatmentevidence-to-practicehealth systemsimplementation sciencemixed methodsoncology careorganizational support and buy-in

Identifiers

PMID35448169
PMCPMC9032473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.